ID

17653

Beschreibung

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Stichworte

Versionen (2)
  1. 02.08.16 02.08.16 -
  2. 27.09.16 27.09.16 -
Hochgeladen am

27. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Englisch

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulare  
Withdrawal of Treatment Consent
Beschreibung

Withdrawal of Treatment Consent

Withdrawal of Treatment Consent: Not Applicable
Beschreibung

Withdrawal of Treatment Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0087111
Patient withdrew treatment consent during the study. Date:
Beschreibung

Date Consent Withdrawn

Datentyp

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Tissue Consent
Beschreibung

Withdrawal of Tissue Consent

Withdrawal of Tissue Consent: Not Applicable
Beschreibung

Withdrawal of Tissue Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0475358
Patient withdrew tumor tissue consent during the study. Date:
Beschreibung

Date Consent Withdrawn

Datentyp

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Optional Research Blood Sample Consent
Beschreibung

Withdrawal of Optional Research Blood Sample Consent

Withdrawal of Optional Research Blood Sample Consent: Not Applicable
Beschreibung

Withdrawal of Optional Research Blood Sample Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0178913
Patient withdrew optional blood sample consent during the study. Date:
Beschreibung

Date Consent Withdrawn

Datentyp

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Investigator Signature
Beschreibung

Investigator Signature

Investigator's Signature
Beschreibung

Investigator Signature

Datentyp

text

Alias
UMLS CUI [1]
C2346576
Signature Date
Beschreibung

Signature date

Datentyp

date

Alias
UMLS CUI [1]
C0807937
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Withdrawal of Treatment Consent
Withdrawal of Treatment Consent
Item
Withdrawal of Treatment Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew treatment consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Tissue Consent
Withdrawal of Tissue Consent
Item
Withdrawal of Tissue Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew tumor tissue consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Optional Research Blood Sample Consent
Withdrawal of Optional Research Blood Sample Consent
Item
Withdrawal of Optional Research Blood Sample Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew optional blood sample consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigator Signature
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Signature date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video